May 2007
Volume 48, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2007
Appearance of Distance / Near Incomitance and of an Accommodative Component in Congenital Esotropia Treated Using Botulinum Toxin
Author Affiliations & Notes
  • N. Alejandre-Alba
    Ophthalmology, Hospital Clinico San Carlos, Madrid, Spain
  • R. Gomez-de-Liano
    Ophthalmology, Hospital Clinico San Carlos, Madrid, Spain
  • C. Roberts
    Ophthalmology, Hospital Clinico San Carlos, Madrid, Spain
  • P. Arriola-Villalobos
    Ophthalmology, Hospital Clinico San Carlos, Madrid, Spain
  • J. Garcia-Sanchez
    Ophthalmology, Hospital Clinico San Carlos, Madrid, Spain
  • Footnotes
    Commercial Relationships N. Alejandre-Alba, None; R. Gomez-de-Liano, None; C. Roberts, None; P. Arriola-Villalobos, None; J. Garcia-Sanchez, None.
  • Footnotes
    Support None.
Investigative Ophthalmology & Visual Science May 2007, Vol.48, 4865. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      N. Alejandre-Alba, R. Gomez-de-Liano, C. Roberts, P. Arriola-Villalobos, J. Garcia-Sanchez; Appearance of Distance / Near Incomitance and of an Accommodative Component in Congenital Esotropia Treated Using Botulinum Toxin. Invest. Ophthalmol. Vis. Sci. 2007;48(13):4865.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose:: A number of patients with congenital esotropia, whose proportion is not currently known, present with associated Distance/Near Incomitance (DNI). In addition a further proportion develop an Accommodative Component (AC) to their strabismus with the passage of time, which at times may lead to the recurrence of esotropia. The object of this study was to evaluate the incidence of DNI and of an accommodative component in patients treated using botulinum Toxin A (BT),in order to assess the value of this form of management in the diagnosis of both DNI and AC in congenital esotropia and the improvement of subsequent surgical planning where it proves necessary.

Methods:: Retrospective study of the clinical histories were studied of 26 patients with congenital esotropia who were treated by means of botulinum toxin.

Results:: 42% of the patients controlled their deviation by the botulin toxin inyections.The annual risk of developing DNI and AC in our sample was 7.9% and 18%.

Conclusions:: Botulinum toxin is a good diagnostic method for both of these since it provides an early intervention that may unmask them (as well as correctly align many patients) and thus subsequent surgery can be successfully individualized.

Keywords: esotropia and exotropia • strabismus: treatment • strabismus: diagnosis and detection 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×